Hi friends! Happy Heat of the Summer, Dog Days of Summer!
If you are like me, you have probably read a lot of lipedema research over the years and thought, “Why does none of this quite line up?”
One study measures pain one way. Another uses a completely different scale. Some talk about staging differently. Others barely mention things like mobility or daily function. It can feel like everyone is studying the same condition, but speaking slightly different languages.
Before I get into this new research, I want to share something personal, because it connects directly to why this matters.
I went nearly 20 years without a diagnosis. I had a primary care provider who was kind, attentive, and genuinely wanted to help me. But like so many providers at the time, lipedema was simply not on their radar. It was not something they had been taught to recognize.
Ironically, it was a foot brace specialist who first asked me questions that made me pause. They noticed patterns in my body that did not quite fit what they expected. That conversation sent me home to the internet, searching.
And that is when everything changed.
For the first time, I saw other women who had legs like mine. Not similar. Not close. The same. That moment is hard to describe, but many of you understand it. It was equal parts relief, validation, and frustration.
That experience is what led me to start sharing my story, writing all kinds of books about lipedema and eventually to advocacy by forming the national nonprofit, American Lipedema Association (have I mentioned that we would love for YOU, patient, provider, caregiver, to join us???).
So when I look at research like this, I am not just reading it as an abstract concept. I am thinking about how many people are still out there, trying to connect the dots on their own.
The real issue behind the scenes
A new paper, called The Lipedema Common Case Report Form as a Research Tool: Standardizing Lipedema Data Collection, published in June 2026 does not offer a treatment breakthrough or a new diagnostic test. Instead, it tries to address a quieter but very real problem in lipedema research.
Lipedema research has grown quickly. More than half of the published studies have come out in just the last few years. That is encouraging, but more studies do not automatically mean clearer answers.
Right now, researchers are not always collecting the same kinds of information or measuring things the same way. That makes it very difficult to compare results across studies, and even harder to combine data.
And that slows progress on the questions patients care about most:
-
How does lipedema actually progress?
-
Why do symptoms vary so much between people?
-
Are there different subtypes?
-
What treatments really work, and for whom?
It also affects how insurers and policymakers view lipedema. When the evidence looks inconsistent, it is easier for them to call it limited or inconclusive.
So what did they create?
The researchers developed something called a Common Case Report Form, or CCRF.
In simple terms, it is a standardized way to collect information in research studies.
Instead of every research team asking different questions in different ways, this form gives them a shared structure. It defines what to ask, how to ask it, and how to record the answers.
It includes information like:
-
Pain levels
-
Body measurements
-
Swelling and tissue changes
-
Medical and family history
-
Medications and surgeries
-
Mobility and daily function
The goal is for studies done in different places to finally be comparable and, over time, combined.
It is important to note that this is not a diagnostic tool and it does not guide treatment. It is strictly for research.
A lot of work went into this
This project took about 22 months to develop.
The team reviewed existing guidelines, surveys, and data standards. When good measurement tools already existed, they used them. When they did not, they created new ones specific to lipedema.
They also involved a wide range of experts, including clinicians, surgeons, statisticians, and people living with lipedema. Patients helped test whether the questions made sense and were reasonable to complete.
That matters. Patient experience should be part of the process, not an afterthought.
Yes, it is long but flexible
The full form includes 682 data elements, which sounds overwhelming.
But it is designed in levels. Researchers can choose a shorter core version that takes about 16 minutes, or use more detailed versions depending on their study. The longest version can take around 45 minutes.
That flexibility is important, especially for people managing pain, fatigue, or long medical visits.
What did the pilot show?
The form was tested with 74 participants at a research event in 2025.
The positives:
-
Participants were able to complete it
-
The data was usable
-
Feedback helped improve the wording and structure
The limitations:
This was a small group, and most participants were White women. Only a small number did not have lipedema, so there was not a strong comparison group.
They also evaluated how well the questions worked together, but the paper does not include all the detailed reliability numbers.
So this is a solid early step, not a final answer.
What this does not do
This is important.
This paper does not:
-
Introduce a new treatment
-
Reduce symptoms
-
Provide a diagnostic test
-
Prove anything about outcomes
What it does is create a tool to support better research in the future.
Why this could matter long term
If researchers begin using the same core data, we may start to see:
-
Studies that can actually be compared
-
Larger combined datasets
-
Better understanding of different types of lipedema
-
More meaningful information about treatment outcomes
Over time, that can influence clinical care, guidelines, and insurance decisions.
But that only happens if the tool is widely used, applied consistently, and supported by strong study design and diverse participation.
A few things I am watching
As this moves forward, I will be paying attention to:
-
Whether researchers consistently use the core data elements
-
Whether studies include diverse populations
-
Whether quality of life is measured alongside physical findings
-
Whether clinicians apply these measures consistently across settings
Because standardization only helps if it is done well.
The bottom line
This is not the breakthrough many of us are waiting for,yet. But it is something we have needed for a long time. A shared framework. A common language for lipedema research.
Without that, it is very difficult to build strong, reliable evidence. So while this will not change your care tomorrow, it has the potential to move the field forward in a more coordinated and meaningful way. And for those of us who spent years searching for answers, anything that helps future patients get there faster is worth paying attention to.
Until next time, stay well, friends,
Susan
Citation:
Galia S, Crescenzi R, Kruppa P, Kartt J, Cochrane JC, Mascio C, Harmacek L, Heil S, Samouhos E, Peterson S, Dean SM, Wright TF, Cifarelli V, Padera TP, Rutkowski JM, Eddens KS, Egan C, Whitehead S, Herbst KL, Bunnell BA, Shawber C, Hucho T, Hinyard L, Al-Ghadban S, Scott AO, Ostergaard P, Pittman A, Nono Nankam PA, Scherer PE, Forner-Cordero I, Damstra RJ, Hendrickx A, Srinivasan A. The lipedema common case report form as a research tool: standardizing lipedema data collection. Front Glob Womens Health. 2026 Jun 24;7:1833913. doi: 10.3389/fgwh.2026.1833913. PMID: 42422575; PMCID: PMC13342235.
